Latest added Gene Therapy Market research study by MarketDigits offers detailed product outlook and elaborates market review till 2026. The market Study is segmented by key regions that is accelerating the marketization. At present, the market is sharping its presence and some of the key players in the study are Abeona Therapeutics, Audentes Therapeutics, AveXis, Bluebird Bio, CRISPR Therapeutics AG, Editas Medicine, GlaxoSmithKline, Intellia Therapeutics. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources.
This report studies the Gene Therapy Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the Gene Therapy Market by companies, region, type and end-use industry.
Request for Free Sample Copy of This Report @ marketdigits.com/gene-therapy-market/sample
Scroll down 100s of data Tables, charts and graphs spread through Pages and in-depth Table of Content on “Gene Therapy Market, By Vector (Non-Viral Vectors, Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, Other Indications), Delivery Method ( In Vivo, Ex Vivo) and Geography – Global Forecast to 2026”. Early buyers will get 10% customization on study.
To Avail deep insights of Gene Therapy Market Size, competition landscape is provided i.e. Revenue Analysis (M $US) by Company (2018-2020), Segment Revenue Market Share (%) by Players (2018-2020) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.
Unlock new opportunities in Gene Therapy Market; the latest release from MarketDigits highlights the key market trends significant to the growth prospects, Let us know if any specific players or list of players needs to consider to gain better insights.
Grab Complete Details with TOC For Free @ marketdigits.com/gene-therapy-market/toc
The global gene therapy market is estimated to grow from USD 3.8 billion in 2019 to USD 13.0 billion by 2024, at a CAGR of 27.8%. The growth of this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursements, and the increasing funding for gene therapy research. However, the high cost of gene therapies is expected to hamper market growth to a certain extent during the forecast period.
The demand for gene therapies for the treatment of cancer is estimated to grow at a high rate during the forecast period
Based on indication, the market is segmented into neurological diseases, cancer, hepatological diseases, Duchenne muscular dystrophy, and other indications. The cancer segment is estimated to grow at the highest CAGR during the forecast period owing to the approval of a growing number of gene therapies for the treatment of cancer and the rising incidence of hematologic cancers.
Non-viral vectors segment accounted for the largest share of the gene therapy market, by vector, in 2018
The market, by vector, has been segmented into viral and non-viral vectors. The non-viral vectors segment accounted for the largest share of the market in 2018. This can be attributed to the high market penetration of oligonucleotide-based non-viral vector gene therapies.
North America is the largest regional market for gene therapies
The global market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the market, followed by Europe. The rising prevalence of chronic diseases, high and growing healthcare expenditure, presence of advanced healthcare infrastructure, availability of reimbursements, and the presence of major market players in the region are the major factors driving the growth of the gene therapy market in North America.
Key Market Players
The prominent players operating in the gene therapy market include Biogen (US), Novartis AG (Switzerland), Gilead Sciences, Inc. (US), Spark Therapeutics, Inc. (US), MolMed S.p.A. (Italy), Orchard Therapeutics plc. (UK), SIBIONO (China), Shanghai Sunway Biotech Co., Ltd. (China), bluebird bio, Inc. (US), Human Stem Cells Institute (Russia), AnGes, Inc. (Japan), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics (US), Jazz Pharmaceuticals, Inc. (Ireland), Akcea Therapeutics (US), and Dynavax Technologies (US).
Biogen was the leading player in the market in 2018. Strong business operations across all key regions, coupled with a strong brand image, have made Biogen a leading player in this market. Biogen adopted organic and inorganic growth strategies, such as agreements & collaborations and acquisitions, to maintain its leading position in the market. For instance, in 2017, Biogen entered into a collaboration with Ionis Pharmaceuticals to identify new antisense oligonucleotide drug candidates for the treatment of spinal muscular atrophy. In 2019, the company received the NMPA (National Medical Products Association) approval in China for SPINRAZA, which is used for treating 5q spinal muscular atrophy.
- In May 2019, Novartis AG (Switzerland) received FDA approval for ZOLGENSMA.
- In June 2019, Biogen (US) acquired Nightstar Therapeutics (UK) to enhance its presence in the market.
- In June 2018, Amgen (US) collaborated with the University of Texas MD Anderson Cancer Center (US) to develop a variety of Amgen’s early-stage oncology therapies.
Key Questions Addressed by the Report
- Where will all these developments take the industry in the mid-to-long term?
- What are the recent trends affecting the market?
- Who are the key players in the market, and how intense is the competition?
- What are the key indications of gene therapy?
- Which region is lucrative for the market?
By understanding and keeping into focus customer requirement, one method or combination of many steps have been employed to structure this most excellent Gene Therapy Market research report. The report is generated with the systematic gathering and analysis of information about individuals or organizations which is conducted through social and opinion research. This global market research report analyses key factors of the industry which offers precise and accurate data and information for the business growth. What is more, competitive analysis gives a clear idea about the strategies used by the major competitors in the Gene Therapy Market that perks up their penetration in the market.
Table of Contents-Snapshot
– Executive Summary
Chapter 1 Industry Overview
Chapter 2 Industry Competition by Manufacturers
Chapter 3 Industry Production Market Share by Regions
Chapter 4 Industry Consumption by Regions
Chapter 5 Industry Production, Revenue, Price Trend by Type
Chapter 6 Industry Analysis by Applications
Chapter 7 Company Profiles and Key Figures in Industry Business
Chapter 8 Industry Manufacturing Cost Analysis
Chapter 9 Marketing Channel, Distributors and Customers
Chapter 10 Market Dynamics
Chapter 11 Industry Forecast
Chapter 12 Research Findings and Conclusion
Chapter 13 Methodology and Data Source
Any Questions? Inquire Here Before Buying @ marketdigits.com/gene-therapy-market/analyst
About Market Digits :
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us :
Phone : +91-9822485644
Email : [email protected]